Publications
Publications
Show Results For
- All HBS Web
(5,521)
- Faculty Publications (1,564)
- June 2021 (Revised November 2021)
- Case
Equity Bank: Charting the Future
By: Lauren Cohen, Michael Chitavi and Spencer C. N. Hagist
After climbing the ranks among Kenya's financial institutions from 66th to 1st, and toppling a quarter of the market share held by mobile money giant Safaricom, CEO James Mwangi must now guide Equity Bank into its next stage of development beyond "Equity 3.0." Should... View Details
- June 10, 2021
- Article
Preparing Hospitals for the Next Pandemic
By: Regina E. Herzlinger and Barak D. Richman
The COVID-19 epidemic response has shown that the U.S. is blessed with heroic physicians and other health care providers, researchers, and facilities. But it has also revealed a health care system that was woefully unprepared for the surge of pandemic patients. In the... View Details
- June 2021
- Case
uBiome
By: Thomas R. Eisenmann and Olivia Graham
uBiome provided clinical tests that sequenced the DNA of human microbiome samples, providing data on health conditions directly to consumers or to prescribing physicians. Founded in 2012, the San Francisco-based startup raised $105 million from top-tier venture capital... View Details
- 2021
- Working Paper
Bank Balance Sheet Constraints and Bond Liquidity
By: Johannes Breckenfelder and Victoria Ivashina
- 2021
- Working Paper
The Great Unequalizer: Initial Health Effects of COVID-19 in the United States
By: Marcella Alsan, Amitabh Chandra and Kosali I. Simon
We measure inequities from the COVID-19 pandemic on mortality and hospitalizations in the United States during the early months of the outbreak. We discuss challenges in measuring health outcomes and health inequality, some of which are specific to COVID-19 and others... View Details
- May 2021 (Revised June 2021)
- Supplement
'GEnron'? Markopolos versus General Electric (B)
By: Jonas Heese and David Lane
Supplement to the (A) case that offers an assessment of the August 2019 Markopolos report on General Electric. View Details
- May 2021
- Article
Fifty Shades of QE: Comparing Findings of Central Bankers and Academics
By: Brian Fabo, Marina Jančoková, Elisabeth Kempf and Ľuboš Pástor
We compare the findings of central bank researchers and academic economists regarding the macroeconomic effects of quantitative easing (QE). We find that central bank papers find QE to be more effective than academic papers do. Central bank papers report larger effects... View Details
- April 2021
- Case
JPMorgan Chase's Path Forward
By: Joseph L. Bower, Nien-hê Hsieh and Michael Norris
In 2020, JPMorgan Chase announced a $30 billion Commitment to Advance Racial Equity. The Commitment included investments in housing, small businesses, and financial literacy across the U.S., and diversity, equity, and inclusion within the bank. It was part of a broader... View Details
- April 2021 (Revised January 2022)
- Case
SA Taxi: A Vehicle for Empowerment? (A)
By: Nien-he Hsieh, Dilyana Karadzhova Botha and F. Christopher Eaglin
SA Taxi was a vertically integrated business that operated in South Africa’s distinctive taxi industry. Despite being plagued by violence, informal structures, unsafe road practices and lack of government support, the taxi industry had grown to become South Africa’s... View Details
- April 2021 (Revised January 2022)
- Supplement
SA Taxi: A Vehicle for Empowerment? (B)
By: Nien-he Hsieh, Dilyana Karadzhova Botha and F. Christopher Eaglin
SA Taxi was a vertically integrated business that operated in South Africa’s distinctive taxi industry. Despite being plagued by violence, informal structures, unsafe road practices and lack of government support, the taxi industry had grown to become South Africa’s... View Details
- April–May 2021
- Article
The Effect of Retaliation Costs on Employee Whistleblowing
By: Jonas Heese and Gerardo Pérez Cavazos
We use large increases in unemployment insurance (UI) benefits to study the effects of expected retaliation costs on employee whistleblowing. Increases in UI benefits reduce the costs that arise from a job loss, one of the costliest forms of retaliation. We find that... View Details
- April–May 2021
- Article
The Influence of Loan Officers on Loan Contract Design and Performance
By: Robert Bushman, Janet Gao, Xiumin Martin and Joseph Pacelli
We investigate the extent to which loan officers generate independent, individual effects on the design and performance of syndicated loans. We construct a large database containing the identities of loan officers involved in structuring syndicated loan deals, allowing... View Details
- March 2021 (Revised October 2021)
- Case
Aligning Mission and Margin at Southern Bancorp
By: Rebecca M. Henderson, Brian Trelstad and Eren Kuzucu
In October 2020, after spending almost a decade to turnaround Southern Bancorp, an Arkansan bank founded with the mission to provide financial services to rural, underserved communities, CEO Darrin Williams is wondering how Southern Bancorp should continue to grow.... View Details
- March 2021
- Supplement
Making Impact Investing Markets: IFC (B)
By: Shawn A. Cole, John Masko and T. Robert Zochowski
In 2018, Thailand’s Bank of Ayudhya (known as Krungsri), was considering whether to participate in the first issue of a new financial instrument from the International Finance Corporation (IFC), known as a gender bond. Building on the success of the Green Bond program... View Details
Keywords: Impact Investment; Development Economics; Developing Countries and Economies; Borrowing and Debt; Credit; Equity; Bonds; Financing and Loans; Growth and Development; Emerging Markets; Non-Governmental Organizations; Corporate Social Responsibility and Impact; Financial Instruments; Gender; Financial Services Industry; Thailand
- March 2021
- Case
Humana (A)
By: Regina E. Herzlinger and Ashley Ifeadike
To implement a bold new strategy, Humana needed to decide how to prioritize the pillars; where to own and where to partner; how much risk is acceptable; and how to continue to deliver strong operational performance while implementing a new strategy. Had the firm made... View Details
- March 2021 (Revised December 2021)
- Supplement
Humana (B) — Strategy Execution
By: Regina E. Herzlinger and Ashley Ifeadike
After Humana debuted its new pillar strategy focused on driving integration across members’ health care experiences, feedback from investors in private conferences and other forums was positive but stressed the need for execution and faced several questions in order to... View Details
- March 2021
- Supplement
Humana (C) — Reorganization
By: Regina E. Herzlinger and Ashley Ifeadike
A summary of Humana's restructuring of its business around its pillars. View Details
- March 2021
- Case
VideaHealth: Building the AI Factory
By: Karim R. Lakhani and Amy Klopfenstein
Florian Hillen, co-founder and CEO of VideaHealth, a startup that used artificial intelligence (AI) to detect dental conditions on x-rays, spent the early years of his company laying the groundwork for an AI factory. A process for quickly building and iterating on new... View Details
Keywords: Artificial Intelligence; Innovation and Invention; Disruptive Innovation; Technological Innovation; Information Technology; Applications and Software; Technology Adoption; Digital Platforms; Entrepreneurship; AI and Machine Learning; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; North and Central America; United States; Massachusetts; Cambridge
- March 2021 (Revised August 2021)
- Case
Apax Partners and Duck Creek Technologies
By: Josh Lerner, Terrence Shu and Alys Ferragamo
This case follows Jason Wright and Umang Kajaria at Apax Partners as they consider an investment in Duck Creek Technologies, a technology provider for property & casualty insurance companies. The deal required a complex carve-out from Accenture, Duck Creek’s parent... View Details
- March 2021
- Article
Active Choice, Implicit Defaults, and the Incentive to Choose
By: John Beshears, James J. Choi, David Laibson and Brigitte C. Madrian
Home-delivered prescriptions have no delivery charge and lower copayments than prescriptions picked up at a pharmacy. Nevertheless, when home delivery is offered on an opt-in basis, the take-up rate is only 6%. We study a program that makes active choice of either home... View Details